The AKT/mTOR pathway is a critical driver of MPNST malignancy [3,37] and targeting of the PI3K/AKT/mTOR pathway is a promising strategy for the treatment of MPNST [16,17,23]. The gene discussed is AKT1; the disease is malignant peripheral nerve sheath tumor.